Inventor · disambiguated record
David B. Frennesson
Also filed as: FRENNESSON DAVID B · FRENNESSON DAVID BERTIL
21 granted patents·3 pending applications·92 citations·filing 2001–2024
93Inventor score
Files withBRISTOL MYERS SQUIBB CO16VIIV HEALTHCARE UK NO 5 LTD3AUSTIN JOEL F1PURANDARE ASHOK VINAYAK1SAULNIER MARK G1
Top patents by PatentIndex Score
24 records- 0195US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0294US7534792B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 19, 2009·30 cites·14 claims
- 0393US7223757B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·16 cites·21 claims
- 0489US7879855B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 1, 2011·10 cites·1 claims
- 0587US10144706B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 4, 2018·7 cites·8 claims
- 0686US11505543B24-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Nov 22, 2022·3 cites·4 claims
- 0779US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 0879US10745382B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 18, 2020·2 cites·25 claims
- 0979US8445676B2Pyrrolotriazine kinase inhibitorsPURANDARE ASHOK VINAYAK·Filed 2009·Granted May 21, 2013·5 cites·10 claims
- 1078US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1177US10590105B21,3-dihydroxy-phenyl derivatives useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 17, 2020·2 cites·8 claims
- 1274US7081454B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 25, 2006·6 cites·20 claims
- 1369US9266880B2Substituted azaindazole compoundsAUSTIN JOEL F·Filed 2011·Granted Feb 23, 2016·2 cites·13 claims
- 1466US6677450B2Topoisomerase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jan 13, 2004·3 cites·9 claims
- 1564US6686385B2Anhydro sugar derivatives of indolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 3, 2004·1 cites·24 claims
- 1663US6610727B2Anhydro sugar derivatives of indolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 26, 2003·1 cites·12 claims
- 1760US6855698B2Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 15, 2005·1 cites·45 claims
- 1856US8592579B2Pyrrolotriazine kinase inhibitorsWITTMAN MARK D·Filed 2012·Granted Nov 26, 2013·0 cites·1 claims
- 1950US9775831B2Combinations comprising biphenyl derivatives for use in the treatment of HCVBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 3, 2017·0 cites·12 claims
- 2046US10617675B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·9 claims
- 2141US2020016136A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 2240US2020055839A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 2338US8673922B2Azaindazole compoundsVELAPARTHI UPENDER·Filed 2011·Granted Mar 18, 2014·0 cites·8 claims
- 2436US9169295B2Macrocycles and macrocycle stabilized peptidesSAULNIER MARK G·Filed 2011·Granted Oct 27, 2015·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →